NCT00760968 - Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis | Biotech Hunter

Enrollment

224

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

TAK-783 and methotrexate

TAK-783 100 mg, tablets, orally, once daily and methotrexate stable dose therapy for up to 12 weeks.

DRUG

Methotrexate

TAK-783 placebo-matching tablets, orally, once daily and methotrexate stable dose therapy for up to 12 weeks.

Trial Locations (25)

Brno-Bohunice

Hlučín

Pilsen

Prague

Uherské Hradiště

Zlín

Daugavpils

Riga

Bucharest

Timișoara

Kemerovo

Moscow

Novosibirsk

Petrozavodsk

Saint Petersburg

Yaroslavl

Yekaterinburg

Košice

Martin

Nové Zámky

Piešťany

Poprad

Trnava

Donetsk

Kyiv